guest :: login
DKFZ
    Search   Submit  
Personalize
  • Your alerts
  • Your baskets
  • Your searches
  Help    
Home > Publications database > Toxicities and outcome after CD19-directed chimeric antigen receptor T-cell therapy for secondary neurolymphomatosis. > Access to Fulltext
  • Information
  • Files
 
 
Toxicities and outcome after CD19-directed chimeric antigen receptor T-cell therapy for secondary neurolymphomatosis. - DKFZ-2024-02121
 
Main document file(s):
    Restricted
      American J Hematol - 2024 - Kaulen - Toxicities and outcome after CD19‐directed chimeric antigen receptor T‐cell therapy
    version 1
    American J Hematol - 2024 - Kaulen - Toxicities and outcome after CD19‐directed chimeric antigen receptor T‐cell therapy.pdf [1.23 MB] 14 May 2025, 14:38
    American J Hematol - 2024 - Kaulen - Toxicities and outcome after CD19‐directed chimeric antigen receptor T‐cell therapy.pdf (pdfa) [831.92 KB] 14 May 2025, 14:38
Similar records

DKFZ :: Search :: Submit :: Personalize :: Help
Powered by Invenio v1.1.7 | join2_v2606a
Maintained by zb.invenio@dkfz-heidelberg.de

Impressum | Data Privacy Policy